NVIDIA partners with AstraZeneca and the University of Florida for AI-powered drug discovery

NVIDIA is collaborating with AstraZeneca and the University of Florida’s academic health center on a transformer-based generative AI model for chemical structures used in drug discovery. The model will be open-sourced, available to researchers & developers in the NVIDIA NGC software catalog. NVIDIA Clara Discovery aims to give researchers tools needed to discover promising pharmaceuticals faster.

Source(s): NVIDIA